SCHEMBL4288652

SCHEMBL4288652

COc1ccc(C(O)c2c(O)cc(C)cc2Cl)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
MAPT P10636 4/20 0.45
MCL1 Q07820 1/20 0.45
BRD4 O60885 1/20 0.39
MAPK1 P28482 3/20 0.39
TSHR P16473 2/20 0.39
GAA P10253 2/20 0.39
CYP3A4 P08684 3/20 0.39
PDE10A Q9Y233 1/20 0.39
ALDH1A1 P00352 3/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
TDP1 Q9NUW8 1/20 0.38
ACHE P22303 1/20 0.37
PPARG P37231 1/20 0.37
LMNA P02545 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
ACLY P53396 1/20 0.36
AOC3 Q16853 1/20 0.36
NPC1 O15118 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23663329 0.91 MEN1 (0.49) MEN1KMT2AMAPTMCL1BRD4
SCHEMBL4285618 0.80 KMT2A (0.43) MEN1KMT2AMAPTMCL1MAPK1
SCHEMBL23663342 0.80 MEN1 (0.48) MEN1KMT2AMAPTMAPK1TSHR
SCHEMBL4287172 0.75 NPBWR1 (0.41) MEN1KMT2AMAPTMCL1MAPK1
SCHEMBL9771548 0.74 MEN1 (0.46) MEN1KMT2AMAPTBRD4MAPK1
SCHEMBL31650897 0.73 ADRB2 (0.39) BRD4MAPK1TSHRTDP1AOC3
SCHEMBL8805726 0.73 ACHE (0.65) KMT2AMAPTBRD4MAPK1TSHR
SCHEMBL28973547 0.73 ACHE (0.65) KMT2AMAPTBRD4MAPK1TSHR
SCHEMBL3602314 0.72 PTGS1 (0.48) MEN1KMT2AMAPTMCL1MAPK1
SCHEMBL120187 0.72 CA12 (0.58) MAPK1TSHRGAAALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-05-28 US disclosed
EP-2048150-A1 BENZYL PHENYL GLUCOPYRANOSIDE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2009-04-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE SLC5A1, SLC5A2, SLC2A1 MEN1 3776/4885KMT2A 1397/4885MAPT 2884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.